COMPARISON STUDY BETWEEN TWO TYPES OF TREATMENT JANU BASTI OF NIRGUNDI TAILA AND MATRA BASTI OF NIRGUNDI TAILA IN PATIENTS OF JANU SANDHIGATA VATA.

A comparative clinical study of two modalities Matra Basti of Nirgundi Taila and Janubasti of Nirgundi Taila in Janu Sandhigata Vata.

Status

Active, not recruiting

Phases

Phase 1Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/04/033105

Enrollment

Registered

2021-04-26

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M179- Osteoarthritis of knee, unspecified

Interventions

Intervention1: MATRA BASTI OF NIRGUNDI TAILA AND JANUBASTI OF NIRGUNDI TAILA: NIRGUNDI TAILA IS A FORMULATION OF AYURVEDIC HERBS IN FORM OF OIL. IN GROUP A MATRA BASTI OF NIRGUNDI TAILA IS ADMINISTERE

Eligibility

Inclusion criteria

Inclusion criteria: PATIENTS FULFILLING THE CRITERIA OF DIAGNOSIS OF JANU SANDHIGATA VATA ACCORDING TO GRANTHAS. AGE 40 TO 60 YEARS. GENDER BOTH MALE AND FEMALE. BASTI ARHA. SNEHANA ARHA. SWEDANA ARHA.

Exclusion criteria

Exclusion criteria: JANU SANDHI SHOOLA ASSOCIATED WITH ANY OTHER SYSTEMIC DISEASE. H/O SEVERE INJURY, FRACTURE, DISLOCATION, TRAUMA OF KNEE JOINT.

Design outcomes

Primary

Measure	Time frame
TO COMPARE THE EFFECT OF TWO MODALITIES MATRA BASTI OF NIRGUNDI TAILA AND JANUBASTI OF NIRGUNDI TAILA IN JANU SANDHIGATA VATA.Timepoint: TREATMENT WILL BE GIVEN FOR 7 DAYS. PATIENT WILL BE ASSESSED ON 1, 3, 7TH DAY.	—

Secondary

Measure	Time frame
TO ASSESS THE EFFECT OF NIRGUNDI TAILA JANUBASTI IN JANU SANDHIGATA VATA WITHIN 7 DAYS.Timepoint: PATIENT WILL BW ASSESSED ON 1, 3, 7 TH DAY.;TO ASSESS THE EFFECT OF NIRGUNDI TAILA MATRA BASTI IN JANU SANDHIGATA VATA WITHIN 7 DAYS.Timepoint: PATIENT WILL BE ASSESSED ON 1, 3, 7TH DAY.	—

Countries

India

Contacts

Public ContactDR PRIYA YASHWANT KALE

SUMATIBHAI SHAH AYURVED MAHAVIDYALAYA

drvandanapalve@gmail.com9890608788

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026